Treating high-risk moderate acute malnutrition using therapeutic food compared with nutrition counseling (Hi-MAM Study): a cluster-randomized controlled trial.
RUTF
Sierra Leone
moderate acute malnutrition
nutrition counseling
supplementary feeding
wasting
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
received:
29
10
2020
accepted:
01
04
2021
pubmed:
9
5
2021
medline:
2
10
2021
entrez:
8
5
2021
Statut:
ppublish
Résumé
There is a lack of consensus on what is the most appropriate treatment of moderate acute malnutrition (MAM). We aimed to determine if provision of ready-to-use-therapeutic food (RUTF) and antibiotics to "high-risk" MAM (HR-MAM) children in addition to nutritional counseling would result in higher recovery and less deterioration than nutrition counseling alone. At the 11 intervention clinics, HR-MAM children were given RUTF and amoxicillin along with standard nutrition counseling, for 2-12 wk. All others received 6 wk of nutrition counseling alone. HR-MAM was defined as midupper arm circumference (MUAC) <11.9 cm, weight-for-age z score (WAZ) <-3.5, mother not the main caregiver, or a child <2 y old not being breastfed. Outcomes were compared using intention-to-treat analysis. Analysis included 573 children at the intervention sites and 714 children at the control sites. Of the intervention group, 317 (55%) were classified as HR-MAM. Short-term recovery was greater at the intervention sites [48% compared with 39% at week 12; risk difference (rd): 0.08; 95% CI: 0.03, 0.13]. The intervention group had lower risk of deteriorating to severe acute malnutrition (SAM) (18% compared with 24%; rd: -0.07; 95% CI: -0.11, -0.04), lower risk of dying (1.8% compared with 3.1%; rd: -0.02; 95% CI: -0.03, -0.00), and greater gains in MUAC and weight than did children at the control sites. However, by 24 wk, the risk of SAM was similar between the 2 arms (31% compared with 34%; rd: -0.03; 95% CI: -0.09, 0.02). Control group data identified recent illness, MUAC <12.0 cm, WAZ <-3, dropping anthropometry, age <12 mo, being a twin, and a history of previous SAM as risk factors for deterioration. Provision of RUTF and antibiotics to HR-MAM children improved short-term recovery and reduced short-term risk of deterioration. However, recovery rates were still suboptimal and differences were not sustained by 6 mo post enrollment.This trial was registered at clinicaltrials.gov as NCT03647150.
Sections du résumé
BACKGROUND
There is a lack of consensus on what is the most appropriate treatment of moderate acute malnutrition (MAM).
OBJECTIVES
We aimed to determine if provision of ready-to-use-therapeutic food (RUTF) and antibiotics to "high-risk" MAM (HR-MAM) children in addition to nutritional counseling would result in higher recovery and less deterioration than nutrition counseling alone.
METHODS
At the 11 intervention clinics, HR-MAM children were given RUTF and amoxicillin along with standard nutrition counseling, for 2-12 wk. All others received 6 wk of nutrition counseling alone. HR-MAM was defined as midupper arm circumference (MUAC) <11.9 cm, weight-for-age z score (WAZ) <-3.5, mother not the main caregiver, or a child <2 y old not being breastfed. Outcomes were compared using intention-to-treat analysis.
RESULTS
Analysis included 573 children at the intervention sites and 714 children at the control sites. Of the intervention group, 317 (55%) were classified as HR-MAM. Short-term recovery was greater at the intervention sites [48% compared with 39% at week 12; risk difference (rd): 0.08; 95% CI: 0.03, 0.13]. The intervention group had lower risk of deteriorating to severe acute malnutrition (SAM) (18% compared with 24%; rd: -0.07; 95% CI: -0.11, -0.04), lower risk of dying (1.8% compared with 3.1%; rd: -0.02; 95% CI: -0.03, -0.00), and greater gains in MUAC and weight than did children at the control sites. However, by 24 wk, the risk of SAM was similar between the 2 arms (31% compared with 34%; rd: -0.03; 95% CI: -0.09, 0.02). Control group data identified recent illness, MUAC <12.0 cm, WAZ <-3, dropping anthropometry, age <12 mo, being a twin, and a history of previous SAM as risk factors for deterioration.
CONCLUSIONS
Provision of RUTF and antibiotics to HR-MAM children improved short-term recovery and reduced short-term risk of deterioration. However, recovery rates were still suboptimal and differences were not sustained by 6 mo post enrollment.This trial was registered at clinicaltrials.gov as NCT03647150.
Identifiants
pubmed: 33963734
pii: S0002-9165(22)00420-8
doi: 10.1093/ajcn/nqab137
pmc: PMC8921644
doi:
Banques de données
ClinicalTrials.gov
['NCT03647150']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
955-964Subventions
Organisme : NIAID NIH HHS
ID : U01 AI103401
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Br J Nutr. 2020 Apr 14;123(7):756-767
pubmed: 31818335
Food Nutr Bull. 2004 Mar;25(1 Suppl):S15-26
pubmed: 15069916
Trans R Soc Trop Med Hyg. 2021 Nov 1;115(11):1317-1329
pubmed: 34535798
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
PLoS Med. 2020 Jul 9;17(7):e1003192
pubmed: 32645109
Am J Clin Nutr. 2021 Sep 1;114(3):955-964
pubmed: 33963734
N Engl J Med. 2013 Jan 31;368(5):425-35
pubmed: 23363496
Nat Rev Dis Primers. 2017 Sep 21;3:17067
pubmed: 28933421
PLoS One. 2016 Apr 21;11(4):e0153530
pubmed: 27100177
J Nutr. 2013 Feb;143(2):215-20
pubmed: 23256140
Am J Clin Nutr. 2017 Aug;106(2):657-666
pubmed: 28615258
Matern Child Nutr. 2020 Jan;16(1):e12898
pubmed: 31667981
PLoS One. 2021 Feb 3;16(2):e0245477
pubmed: 33534818
Arch Public Health. 2018 Jul 16;76:28
pubmed: 30026945
PLoS One. 2020 Jun 3;15(6):e0230452
pubmed: 32492023
Am J Clin Nutr. 2014 Jul;100(1):241-9
pubmed: 24808482
Int J Environ Res Public Health. 2017 Apr 11;14(4):
pubmed: 28398257
J Nutr. 2015 Nov;145(11):2604-9
pubmed: 26423737
PLoS One. 2017 Sep 21;12(9):e0182096
pubmed: 28934235